J
Jacques Donzé
Researcher at Brigham and Women's Hospital
Publications - 63
Citations - 2310
Jacques Donzé is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 18, co-authored 49 publications receiving 1595 citations. Previous affiliations of Jacques Donzé include University of Lausanne & Harvard University.
Papers
More filters
Journal ArticleDOI
Potentially Avoidable 30-Day Hospital Readmissions in Medical Patients Derivation and Validation of a Prediction Model
TL;DR: This simple prediction model identifies before discharge the risk of potentially avoidable 30-day readmission in medical patients and has potential to easily identify patients who may need more intensive transitional care interventions.
Journal ArticleDOI
Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial.
Philipp Schuetz,Rebecca Fehr,Valerie Baechli,Martina Geiser,Manuela Deiss,Filomena Gomes,Alexander Kutz,Pascal Tribolet,Thomas Bregenzer,Nina Braun,Claus Hoess,Vojtech Pavlicek,Sarah Schmid,Stefan Bilz,Sarah Sigrist,Michael Brändle,Carmen Benz,Christoph Henzen,Silvia Mattmann,Robert Thomann,Claudia Brand,Jonas Rutishauser,Drahomir Aujesky,Nicolas Rodondi,Jacques Donzé,Jacques Donzé,Zeno Stanga,Beat Mueller +27 more
TL;DR: These findings strongly support the concept of systematically screening medical inpatients on hospital admission regarding nutritional risk, independent of their medical condition, followed by a nutritional assessment and introduction of individualised nutritional support in patients at risk.
Journal ArticleDOI
Causes and patterns of readmissions in patients with common comorbidities: retrospective cohort study.
Jacques Donzé,Stuart R. Lipsitz,Stuart R. Lipsitz,David W. Bates,David W. Bates,Jeffrey L. Schnipper,Jeffrey L. Schnipper +6 more
TL;DR: In patients with a comorbidity of heart failure, diabetes, ischemic heart disease, atrial fibrillation, or chronic kidney disease, the most common diagnosis of potentially avoidable readmission was acute heart failure.
Journal ArticleDOI
Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy
Jacques Donzé,Carole Clair,Balthasar L. Hug,Nicolas Rodondi,Gérard Waeber,Jacques Cornuz,Drahomir Aujesky +6 more
TL;DR: It is suggested that being at risk of falls is not a valid reason to avoid oral anticoagulants in medical patients, and patients on oral antICOagulant with high falls risk have an increased risk of major bleeding.
Journal ArticleDOI
Scores to Predict Major Bleeding Risk During Oral Anticoagulation Therapy: A Prospective Validation Study
TL;DR: The performance of 7 clinical scoring systems in predicting major bleeding events in patients receiving oral anticoagulant therapy was poor and not better than physicians' subjective assessments.